Cancer treatment is becoming increasingly personalized, and biomarkers play a key role in guiding care. This webinar with medical oncologist and Sharsheret Medical Advisory Board member, Ethan Wasserman, MD, will explore how biomarker testing helps identify the unique characteristics of a cancer, enabling healthcare providers to tailor treatments to an individual's disease. Participants will learn how biomarkers can influence treatment decisions, identify targeted therapy options, predict treatment response, and support more precise, effective cancer care. Whether newly diagnosed, navigating treatment, or living with metastatic disease, attendees will gain a better understanding of how biomarker-driven medicine is shaping the future of oncology.
Bonus for our Embrace Community: We invite members of our Embrace community, those facing metastatic breast cancer or advanced ovarian cancer, to stay on at the end of the webinar for an intimate breakout session with our expert and Bonnie Beckoff, Director of Sharsheret Support Services.
Questions? Contact Melissa Rosen at [email protected].
With support from:
The Embrace Breakout Session is sponsored by:
and 
*Disclaimer:
By joining this program I understand and acknowledge that Sharsheret is not providing medical advice. Additionally, I release and waive Sharsheret from any liability in the event of any accident or injury I may incur either during the course of this webinar or in performing any of the activities discussed during the same.
All views shared on the webinar are of the speakers and are independent of the program sponsors. To the best knowledge of Sharsheret, no relationship exists between the sponsors and the speakers, and no payment has or will be made by the sponsor to the speakers in connection with this webinar.
